We are live on
!
Find out more
KFC
Klingenstein Fields & Co Portfolio holdings
AUM
$2.86B
1-Year Est. Return
28.26%
This Fund
S&P 500
This Quarter
Est. Return
+0.23%
1 Year Est. Return
+28.26%
3 Year Est. Return
+93.38%
5 Year Est. Return
+106.8%
10 Year Est. Return
+364.29%
AUM
$2.24B
AUM Growth
-$19.4M
(-0.86%)
Cap. Flow
-$15.9M
Cap. Flow
% of AUM
-0.71%
Top 10 Holdings %
Top 10 Hldgs %
39.95%
Holding
259
New
10
Increased
35
Reduced
117
Closed
10
Avg Time Held
6.9
quarters
Top 10 Avg Time Held
5.8
quarters
Top 20 Avg Time Held
6.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$19.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$2.79M |
| 3 |
JPMorgan Chase
JPM
|
+$2.3M |
| 4 |
Newell Brands
NWL
|
+$2.21M |
| 5 |
Kirby Corp
KEX
|
+$1.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$12.7M |
| 2 |
Amgen
AMGN
|
+$4.26M |
| 3 |
Invesco Senior Loan ETF
BKLN
|
+$3.24M |
| 4 |
PNC Financial Services
PNC
|
+$2.88M |
| 5 |
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
+$2.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.04% |
| 2 | Communication Services | 16.22% |
| 3 | Financials | 14.6% |
| 4 | Healthcare | 12.83% |
| 5 | Consumer Staples | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Quest Diagnostics
DGX
$25.6B
| $290K | 0.01% |
4,000
| – | – |
2013 Q2
8 quarters
|
|
|
WFM
202
DELISTED
Whole Foods Market Inc
WFM
| $288K | 0.01% |
7,310
+2,000
| +38% | +$89.4K |
2014 Q3
3 quarters
|
|
|
SNLN
203
DELISTED
Highland/iBoxx Senior Loan ETF
SNLN
| $286K | 0.01% |
14,875
| – | – |
2013 Q3
7 quarters
|
|
204
SPX Corp
SPXC
$8.41B
| $281K | 0.01% |
15,407
+4,248
| +38% | +$82.9K |
2013 Q2
8 quarters
|
|
|
DTV
205
DELISTED
DIRECTV COM STK (DE)
DTV
| $281K | 0.01% |
3,033
-600
| -17% | -$54.2K |
2013 Q2
8 quarters
|
|
206
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.17B
| $277K | 0.01% |
10,000
| – | – |
2013 Q2
8 quarters
|
|
207
Edgewell Personal Care
EPC
$1.31B
| $276K | 0.01% |
2,100
-733
| -26% | -$75.6K |
2014 Q2
4 quarters
|
|
208
Rockwell Automation
ROK
$47.5B
| $275K | 0.01% |
2,210
-100
| -4% | -$12K |
2014 Q4
2 quarters
|
|
209
Danaher
DHR
$157B
| $274K | 0.01% |
4,761
| – | – |
2013 Q2
8 quarters
|
|
210
VanEck Pharmaceutical ETF
PPH
$1.03B
| $269K | 0.01% |
3,800
-1,000
| -21% | -$72K |
2013 Q2
8 quarters
|
|
211
iShares Select Dividend ETF
DVY
$22.7B
| $267K | 0.01% |
3,555
-200
| -5% | -$15.6K |
2013 Q2
8 quarters
|
|
212
Bank of Montreal
BMO
$115B
| $266K | 0.01% |
4,483
| – | – |
2014 Q2
4 quarters
|
|
213
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $266K | 0.01% |
+6,500
| New | +$279K |
2015 Q2
0 quarters
|
|
|
BCR
214
DELISTED
CR Bard Inc.
BCR
| $265K | 0.01% |
1,550
| – | – |
2013 Q4
6 quarters
|
|
215
Autoliv
ALV
$8.27B
| $251K | 0.01% |
2,981
| – | – |
2014 Q4
2 quarters
|
|
216
Cullen/Frost Bankers
CFR
$9.38B
| $251K | 0.01% |
3,200
| – | – |
2013 Q2
8 quarters
|
|
|
SIAL
217
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $251K | 0.01% |
1,800
| – | – |
2014 Q3
3 quarters
|
|
218
Hershey
HSY
$32.8B
| $249K | 0.01% |
2,806
| – | – |
2013 Q2
8 quarters
|
|
219
Everest Group
EG
$14.4B
| $246K | 0.01% |
1,350
| – | – |
2013 Q4
6 quarters
|
|
220
Phillips 66
PSX
$115B
| $246K | 0.01% |
3,058
| – | – |
2013 Q2
8 quarters
|
|
|
AVOL
221
DELISTED
AVOLON HLDGS LTD SHS (CYM)
AVOL
| $243K | 0.01% |
10,600
| – | – |
2015 Q1
1 quarter
|
|
222
iShares Russell 1000 Growth ETF
IWF
$129B
| $242K | 0.01% |
9,764
-336
| -3% | -$8.45K |
2013 Q2
8 quarters
|
|
223
iShares Russell 2000 ETF
IWM
$77.8B
| $240K | 0.01% |
1,922
+122
| +7% | +$15.2K |
2015 Q1
1 quarter
|
|
224
Morgan Stanley
MS
$296B
| $240K | 0.01% |
6,200
| – | – |
2014 Q2
4 quarters
|
|
225
Tapestry
TPR
$23B
| $238K | 0.01% |
6,883
| – | – |
2014 Q3
3 quarters
|
|
Similar funds
IA
SEGHC
CPCPP
HJGA
WGI
EMFAT
AF
ORCP
Klingenstein Fields & Co's Q2 2015 Portfolio in Review
As of Q2 2015, Klingenstein Fields & Co held 259 positions worth $2.24B, down 0.86% from $2.26B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Klingenstein Fields & Co's Q2 2015 filing shows 10 new, 35 increased, 117 reduced and 10 closed positions. Its largest new stake was Thermo Fisher Scientific: 21,412 shares worth $2.78M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $12.7M.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 20% a quarter earlier, followed by Communication Services and Financials.
- Klingenstein Fields & Co's largest Q2 2015 buy was Thermo Fisher Scientific: 21,412 shares worth $2.78M.
- Klingenstein Fields & Co added most to Bed Bath & Beyond Inc in Q2 2015, an estimated $19.3M increase.
- Klingenstein Fields & Co's biggest Q2 2015 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $12.7M.
- Klingenstein Fields & Co fully exited PNC Financial Services in Q2 2015, selling an estimated $2.88M.
- Klingenstein Fields & Co's ten largest holdings make up 40% of its $2.24B portfolio in Q2 2015.
- Klingenstein Fields & Co opened 10 new positions and closed 10 in Q2 2015.
- Klingenstein Fields & Co's portfolio value fell 0.86% quarter-over-quarter to $2.24B.
Based on Klingenstein Fields & Co's 13F filing for Q2 2015, filed 3 Aug 2015.